{{Rsnum
|rsid=1394125
|Gene=UBE2Q2
|Chromosome=15
|position=75866642
|Orientation=plus
|GMAF=0.2511
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=UBE2Q2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.4 | 45.1 | 42.5
| HCB | 0.7 | 12.4 | 86.9
| JPT | 1.8 | 15.9 | 82.3
| YRI | 6.8 | 46.6 | 46.6
| ASW | 8.8 | 47.4 | 43.9
| CHB | 0.7 | 12.4 | 86.9
| CHD | 0.9 | 15.9 | 83.2
| GIH | 3.0 | 31.7 | 65.3
| LWK | 13.8 | 52.3 | 33.9
| MEX | 3.4 | 32.8 | 63.8
| MKK | 16.8 | 52.3 | 31.0
| TSI | 20.8 | 45.5 | 33.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20383146
|Trait=Chronic kidney disease
|Title=New loci associated with kidney function and chronic kidney disease
|RiskAllele=A
|Pval=3E-17
|OR=0.01
|ORtxt=[0.007-0.011] ml/min/1.73 m2 decrease
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23263486
  |Trait=Urate levels
  |Title=Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
  |RiskAllele=A
  |Pval=3E-13
  |OR=.04
  |ORtxt=[0.031-0.055] mg/dl increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}